The potential role of the microbiome-gut-brain axis in this interaction.
J&J targets 2024 for Ottava FDA filing
Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Johnson & Johnson on Tuesday